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An acid-compatible co-polymer for the
solubilization of membranes and proteins
into lipid bilayer-containing nanoparticles†
Stephen C. L. Hall, *a,b Cecilia Tognoloni,c Jack Charlton,a Éilís C. Bragginton,d
Alice J. Rothnie,e Pooja Sridhar,a Mark Wheatley, a,g Timothy J. Knowles,a
Thomas Arnold, b,c,f Karen J. Edler c and Tim R. Daﬀorna
The fundamental importance of membrane proteins in drug discovery has meant that membrane mimetic
systems for studying membrane proteins are of increasing interest. One such system has been the amphi-
pathic, negatively charged poly(styrene-co-maleic acid) (SMA) polymer to form “SMA Lipid Particles”
(SMALPs) which have been widely adopted to solubilize membrane proteins directly from the cell
membrane. However, SMALPs are only soluble under basic conditions and precipitate in the presence of
divalent cations required for many downstream applications. Here, we show that the positively charged
poly(styrene-co-maleimide) (SMI) forms similar nanoparticles with comparable eﬃciency to SMA, whilst
remaining functional at acidic pH and compatible with high concentrations of divalent cations. We have
performed a detailed characterization of the performance of SMI that enables a direct comparison with
similar data published for SMA. We also demonstrate that SMI is capable of extracting proteins directly
from the cell membrane and can solubilize functional human G-protein coupled receptors (GPCRs)
expressed in cultured HEK 293T cells. “SMILPs” thus provide an alternative membrane solubilization
method that successfully overcomes some of the limitations of the SMALP method.
Introduction
With an increasing interest in membrane proteins due to their
physiological and pharmacological significance,1–4 recent
developments have yielded alternative solutions to the solubil-
ization bottleneck often limiting purification and
characterization.5–10 A commonly adopted method involves the
use of the amphipathic, helical membrane scaﬀold proteins
(MSP),11 or peptides inspired by the amino acid residue
sequence of the MSP helix,12–14 to solubilise phospholipid
vesicles containing reconstituted membrane proteins into so-
called ‘nanodiscs’. These MSP or peptide-stabilized nanodiscs
have proven a valuable tool for stabilizing membrane proteins
within a planar, nanoscale segment of lipid bilayer surrounded
by a proteinaceous belt. MSP nanodiscs have been used exten-
sively for a variety of targets and applications.10,15,16 While it
has been observed that peptide-stabilized nanodiscs are poten-
tially more amenable to studying protein complexes within the
nanodisc environment,17,18 they have been shown to have a
higher polydispersity than the MSP variety.14 However, both
these protein-stabilized nanodisc systems still suﬀer from the
limitation that encapsulated membrane proteins need to be
extracted using detergent-mediated solubilization before
reconstitution into nanodiscs which can lead to instability and
disruption of protein–protein interactions. In addition, the
peptide nature of the stabilizing belt can lead to spectroscopic
interference in downstream applications such as UV circular
dichroism (UV-CD) spectroscopy.
An alternate strategy is the use of poly(styrene-co-maleic
acid) (SMA) (Fig. 1a) to extract nanodiscs containing a segment
of native cell bilayer, encapsulated by the SMA polymer
(termed SMA lipid particles, SMALPs).19–22 Since the first
report of SMA-mediated solubilization19 the method has been
successfully employed to solubilize a wide variety of targets
directly from a range of biological membranes.23–28 SMALPs
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have also proven useful in downstream functional23,25,29 and
structural characterization.22,24,30–32
The commonly used variants of the SMA polymer have now
been investigated thoroughly21,33–39 showing that the first used
polymer (SMA2000) is the best performing of the polymers so
far studied. However, SMA has its limitations. Firstly, the
nanodiscs formed by commercially available SMA have a dia-
meter of ∼10 nm 20 which potentially limits the size of proteins
that can be solubilized. Secondly, the styrene moiety
shows significant absorption of UV light,40 which overlaps
with the absorption from aromatic residues within proteins.
This interferes with spectroscopic techniques to study solubil-
ized proteins. Thirdly, SMALPs have been shown to be
unstable in the presence of divalent cations such as Mg2+, with
precipitation of the polymer occurring under such conditions.
Although this can be a useful property under certain circum-
stances, it can also be a limitation for many potential down-
stream applications where divalent cations are necessary for
membrane protein function.41,42 Finally, SMA is pH sensitive;
at acidic pH values, maleic acid groups become protonated
and the polymer becomes insoluble.39 This limits the SMALP
method to proteins that are stable at basic pHs.
It is both the success and the limitations of the SMA
polymer which has spawned a drive to investigate other amphi-
pathic polymers which are capable of solubilizing lipid bilayers
into colloidal disc-shaped particles.43–45 Given the high UV
absorbance of styrene, recent advances have been made in
establishing the use of styrene-free polymers for nanodisc for-
mation. The first of these copolymers to be investigated was
poly(diisobutylene-co-maleic acid) (DIBMA) shown to be suc-
cessful in the solubilization of phospholipid membranes and
membrane proteins whilst providing a more native-like phos-
pholipid environment than SMALP nanodiscs.40,46
Additionally, poly(methacrylate) (PMA) polymers, inspired by
the amphiphilic nature of the MSP helix, have been shown to
be functional in nanodisc formation.47 PMA-stabilised nano-
discs have been applied to stabilization of helical intermedi-
ates of amyloid proteins in the presence of a phospholipid
membrane. Currently, the eﬃciency of PMA for solubilization
of biological membranes is unknown. In order to address the
limited size range of nanodiscs formed by SMA, modification
of a low-molecular weight SMA polymer by an amination reac-
tion to form SMA-EA has been shown to form so-called ‘macro
nanodiscs’.48,49 SMA-EA stabilized nanodiscs have been shown
to have diameters up to ∼60 nm whilst exhibiting alignment
properties in external magnetic fields with demonstrated
applications in 2D solid state NMR spectroscopy.
While these new polymers have addressed the issues of UV
absorbance, tolerance to low concentrations of divalent
cations in solution and size limitations, they are still limited
by the same pH constraints as SMA. Two SMA-derived poly-
mers have recently been developed to allow nanodisc for-
mation under acidic conditions. The first such polymer to be
developed, SMAd-A, involves modification of SMA with a
primary amine. SMAd-A can tolerate low pH and is functional
in the solubilization of phospholipids into nanodiscs.50 SMAd-
A stabilized nanodiscs have been demonstrated to provide an
encapsulation platform for the solubilization of hydrophobic
drugs in aqueous media. Most recently, modification of SMA
with a quaternary ammonium has yielded a polymer (SMA-QA)
which is capable of forming nanodiscs.51 SMA-QA-stabilized
nanodiscs have been shown to remain soluble between pH 2.5
and pH 10, oﬀering a substantial improvement in pH-stability
Fig. 1 (a) Structures of SMA and SMI. In both cases, i = 2n. (b)
Representative transmission electron micrograph (TEM) of
DMPC-SMILPs negatively stained with phosphotungstic acid. (c)
Frequency distribution of SMILP diameters imaged with TEM. Bars rep-
resent the mean frequency associated with analysis of three separate
micrographs with error bars representing ±1 standard deviation. The
data ﬁt to the sum of two Gaussian populations of particles (red curve,
dashed curve and shaded region represents the standard error associ-
ated with nonlinear regression) with maxima at diameters of 6 nm
(green line) and 11 nm (blue line).
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compared to the original SMA polymers. Furthermore,
SMA-QA is also able to form macro-nanodiscs of ∼30 nm dia-
meter to overcome the size limitation of SMA-stabilized nano-
discs. However, neither SMAd-A or SMA-QA is commercially
available, requiring synthesis through modification of an SMA
backbone, and neither have been shown to be compatible with
membrane protein solubilization.
Given the limitations discussed above, we have investigated
whether an alternative polymer with a similar structure to
SMA; poly(styrene-co-maleimide) (SMI) (Fig. 1a) can be used in
the self-assembly of phospholipid nanodiscs under acidic con-
ditions. SMI is a commercially available amphipathic copoly-
mer of styrene and dimethylaminopropylamine maleimide in
a 2 : 1 ratio. SMI has been used to create nanoparticles52
capable of oil microencapsulation53 and as a surface coating
with application to printing.54 Despite exploitation of the
amphipathic properties of SMI, there have been no reports on
SMI-mediated phospholipid solubilization.
Here, we demonstrate that SMI is capable of solubilizing
phospholipids by self-assembling in the same way as seen for
SMA. We refer to the resulting nanodisc particles as SMI lipid
particles (SMILPs). SMI exhibits high thermodynamic
eﬃciency in nanodisc self-assembly which is comparable with
SMA. Furthermore, we demonstrate that the size of the lipid
core of SMILPs can be tuned as a function of polymer : lipid
ratio. SMI circumvents some of the limitations of SMA-
mediated solubilization by being tolerant to high concen-
trations of divalent cations and is soluble in acidic conditions.
As SMA is widely used in membrane protein solubilization, we
present data to show that SMI is also capable of extracting
functional membrane proteins directly from cell membranes
without laborious reconstitution following detergent solubil-
ization. These data establish SMI and SMILPs as an alternative
to SMA that is an eﬃcient and eﬀective platform for mem-
brane and protein solubilization under acidic conditions.
Results
SMI-mediated nanodisc self-assembly
We initially investigated whether SMI in the presence of phos-
pholipids is able to self-assemble into discoidal structures.
SMI was added to a suspension of 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) vesicles and analyzed by negative
stain transmission electron microscopy (TEM) (Fig. 1b). The
absence of vesicles and the clear presence of discrete particles
suggests lipid has been solubilized by SMI. A Gaussian ana-
lysis of the size distribution in multiple TEM images (Fig. 1c)
shows a distribution of diameters with two maxima at 6 ±
1 nm and 11 ± 3 nm. This distribution is similar to that pre-
viously determined for SMALP nanodiscs by TEM.19,20
Having confirmed the capability of SMI to form nano-
particles which conform to the size of previously observed
nanodiscs19,20 we tested the thermodynamic eﬃciency of
SMILP self-assembly using 31P-NMR spectroscopy, the prin-
ciples of which have been described previously21,34,37,40
(see Fig. 2). DMPC small unilamellar vesicles (SUVs) alone
gave a broad 31P peak. Upon addition of SMI at concentrations
below that required for the onset of solubilization (the satur-
ation boundary, cSATS ) this peak broadened beyond detection.
This, we believe, is due to low concentrations of SMI causing
aggregation of DMPC, rather than solubilization, as previously
reported for SMA(3 : 1),21,37 SMA(2 : 1)34 and DIBMA40 poly-
mers. Increasing SMI concentration beyond cSATS led to the
appearance of an isotropic 31P peak (Fig. 2a) which linearly
increased in area with increasing SMI concentration, corres-
ponding to the proportion of lipids solubilized. Beyond the
SMI concentration at which all lipids are solubilized, cSOLS , all
the lipids are present within a nanodisc phase. Plotting 31P
peak area against SMI concentration (Fig. 2b) allowed determi-
nation of the cSATS and c
SOL
S breakpoints at diﬀerent DMPC con-
centrations. Plotting the breakpoints obtained as SMI concen-
tration against DMPC concentration (Fig. 2c), enabled defi-
nition of the phase diagram for SMI-mediated solubilization of
DMPC SUVs. This phase diagram gives the molar ratios of
SMI : DMPC required for saturation, Rb;SATS , and solubilization,
Rm;SATS , from which we can calculate the free energy changes
for the vesicle to nanodisc transition associated with DMPC,
ΔGb!m;0Lipid , and SMI, ΔG
b!m;0
Polymer.
21 These values are compared
(Table 1) with equivalent values obtained for two other poly-
mers known to form nanodiscs; SMA2000 and DIBMA.
SMA2000 is the SMA polymer variant most similar to SMI
structurally and DIBMA is a recently developed polymer.40
Structural characterisation of SMILP nanodiscs
To this point we have assumed that the structure adopted by
SMI-DMPC aggregates is, by analogy to SMA, that of a “nano-
disc”. This conclusion is supported by the provisional struc-
tural data presented here.
We have monitored particle size over the self-assembly
process using dynamic light scattering (DLS) (Fig. 3a and S1†).
Below the saturation boundary, a large z-average diameter was
observed. This agrees well with 31P-NMR data discussed above,
and with previous reports using the SMA(2 : 1),33,34 SMA
(3 : 1)21,37 and DIBMA40 polymers. As polymer concentration
increases beyond the SAT boundary, a rapid decrease of
z-average diameter and polydispersity index (PDI) is observed
(Fig. 3a). As mentioned above, we believe this corresponds to
the solubilization of the large non-uniform vesicles into
SMILPs. Beyond the solubilization boundary, the remaining
SMILP aggregates continue to decrease in size by 48% from
11.99 ± 0.26 nm at the SOL boundary to 6.23 ± 0.29 nm dia-
meter at the highest concentration measured. When monitor-
ing the particle size distributions above cSOLS (Fig. 3b), a clear
shift can be seen towards smaller diameters. These data com-
bined with a relatively constant PDI, suggests that this shift in
diameter is not being skewed by excess free polymer in solu-
tion. This capacity of SMILPs to be tuneable in size could be
beneficial to numerous applications where size is an impor-
tant parameter.
To improve the structural detail provided by the low resolu-
tion DLS data, we have performed small angle X-ray scattering
Nanoscale Paper
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(SAXS) using beamline B21 at Diamond Light Source. We
examined SMILPs formed using diﬀerent polymer : lipid ratios
above cSOLS (Fig. 3c). The data were fitted with to a polydisperse
core–shell bicelle model (see ESI Table S1 and Fig. S2†) which
has been used previously to gain structural insight into SMALP
nanodiscs,20 but with a summed ellipsoid model to account
for excess SMI. As can be seen in Fig. 3c, this summed model
provided a good fit to the SMILPs. The corresponding fit para-
meters are shown in Table 2. The structural parameters for
DMPC (headgroup and tail sizes and scattering lengths) were
fixed based on values from comparable studies.20
The mass of the SMILP nanodiscs was also investigated by
size exclusion chromatography with multiple angle light scat-
tering (SEC-MALS)56 (Fig. 3d). These data show negligible
aggregated material since there is no strong signal eluting
from the column at the 8 mL void volume. After this, two
major peaks eluted, the first of which shows both strong light
scattering intensity, indicating the presence of large particles,
and UV absorption signals, indicating the presence of styrene
from SMI. We have assigned this peak to SMILPs. It gives a
mass averaged Mw of 104.7 ± 0.8 kDa, a number averaged Mn
of 102.8 ± 4.4 kDa, resulting in a PDI of 1.02. In-line DLS
further confirms the presence of SMILPs; giving a hydrodyn-
amic diameter of 8.68 ± 0.87 nm, consistent with the range of
SMILP diameters observed by independent DLS. The second
peak shows a strong UV absorbance yet low scattering inten-
sity. The Mw and Mn of this peak are 26.7 ± 3.5 kDa and 26.3 ±
3.31 kDa respectively, giving a PDI of 1.01. A hydrodynamic
radius was measured to be 7.44 nm. This peak has been
assigned to excess SMI polymer aggregates in solution by
account of the decreased scattering intensity yet strong UV
absorption. Further downstream peaks were also seen with UV
yet gave no discernable scattering intensity. We propose these
peaks are due to the presence of short oligomeric polymers
which are present as a by-product of SMI synthesis.
To provide further evidence of the size-tuneability of
SMILPs, SEC-MALS was performed on 1.5% SMI and SMILPs
made at the same SMI : DMPC ratios as measured by SAXS
(Fig. 3e). SEC-MALS of SMI in the absence phospholipids con-
firms our earlier assignment of the second peak in Fig. 3d
being due to SMI aggregates. SMILPs formed at higher
SMI : DMPC ratios show the same trend as observed by SAXS
and DLS, exhibiting higher retention volumes on the column,
indicating formation of smaller particles. The MW calculations
from light scattering data and hydrodynamic diameter
measured by in-line DLS also agree with this assertion, with
SMILPs formed at a higher SMI : DMPC ratio having a both a
lower mass and smaller diameter (Table S2†). In addition, the
ratio of the UV peaks corresponding to SMILPs and SMI
decreases indicating that at higher DMPC concentrations,
more SMI associates with the nanodiscs while the proportion
of SMI forming lipid-free aggregates in solution decreases.
Stability of SMILPs
A limitation of SMA in many downstream biological appli-
cations is the low tolerance to divalent cations and insolubility
at low pH. The polyimide structure of SMI inherently means
Fig. 2 Thermodynamics of SMILP self-assembly. (a) Representative 31P-NMR spectra showing an increasing peak area as 7.5 mM DMPC small unila-
mellar vesicle suspensions are solubilized by increasing SMI concentration from 0 mM SMI (dark blue spectrum) to 1.5 mM SMI (red spectrum).
(b) Normalized 31P-NMR peak area plotted as a function of polymer concentration with corresponding ﬁts to the experimental data to obtain saturation
(SAT) and solubilization (SOL) break points. Each point is the mean of three separate measurements with error bars representing ± standard error. (c) The
phase diagram for SMI solubilizing DMPC constructed using SAT and SOL breakpoints determined from b. The SAT boundary is shown as a blue line and
the SOL boundary is shown as a red line. Points represent cSATs and c
SOL
s breakpoints with error bars representing standard error determined from the
ﬁtting procedure in a and b. The shaded region bound by dashed lines represent the 95% conﬁdence bands associated with linear regression.
Table 1 Thermodynamic parameters obtained for DMPC-SMILP nano-
discs compared with equivalent data from other nanodisc forming poly-
mers SMA200033 and DIBMA40
SMI SMA2000 DIBMA
Rb;SATS 0.021 ± 0.002 0.050 ± 0.003 0.03 ± 0.005
Rm;SATS 0.107 ± 0.013 0.133 ± 0.004 0.062 ± 0.004
ΔGb!m;0Lipid /kJ mol
−1 0.20 ± 0.07 0.19 ± 0.06 0.077 ± 0.01
ΔGb!m;0Polymer/kJ mol
−1 −3.90 ± 0.11 −2.23 ± 0.08 −1.76 ± 0.09
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that it behaves diﬀerently to SMA. We therefore directly com-
pared the stability of SMALPs and SMILPs in the presence of
Ca2+ or Mg2+ or as a function of pH (Fig. 4). This was done by
measuring the turbidity of nanodisc solutions (Fig. 4a & b).
The data show that SMALPs begin to precipitate at 5 mM Mg2+
and 4 mM Ca2+, as indicated by an increased turbidity, with
severe precipitation occurring above 10 mM in both cases.
SMILPs, however, can tolerate concentrations of Mg2+ and Ca2+
in excess of 100 mM. The pH dependence for the two polymers
shows an intuitive trend; SMALPs are only soluble at pH values
>5.8, but SMILPs are only soluble below pH 7.8. This gives
SMILPs a broad working pH range, and importantly allows
studies at physiological pH (7.4).
In addition, SMILPs exhibit high thermal stability as moni-
tored by DLS (Fig. 4c & d). We observed no significant changes
to polydispersity up to 80 °C and no changes in diameter over
a wide temperature range (16 °C–80 °C) However, there was a
decrease in diameter between 10 °C and 16 °C. Importantly,
we observed no signs of aggregation or precipitation at elev-
ated temperature. We also observed that the diameter of the
particles increased from 6.05 ± 0.10 nm to 7.58 ± 0.78 nm after
multiple freeze–thaw cycles. This is not enough to suggest
Fig. 3 Structural characterization of DMPC-SMILP nanodiscs. (a) DLS data showing the eﬀect of SMI concentration on Z-average diameter (red) and
polydispersity Index (PDI – blue). SAT and SOL boundaries obtained from 31P NMR are shown as dashed blue and red lines respectively. Points rep-
resent the mean and shaded regions indicate the standard error obtained from three separate experiments. (b) Volume weighted particle size distri-
bution (PSD) data showing the hydrodynamic diameter (Dh) for SMILPs formed at SMI concentrations above cSOLs . Lines represent the mean PSD of
three separate experiments. Error bars are not shown for clarity. (c) Small angle X-ray scattering (SAXS) curves for DMPC-SMILPs made with 1.5%
(w/v) SMI with 3, 5 and 7 mg mL−1 DMPC (green, blue and red respectively). Points represent the measured scattering intensity, while lines represent
the ﬁt to the experimental data. (d) SEC-MALS chromatogram corresponding to SMI-DMPC nanodiscs made with 1.5% (w/v) SMI and 5 mg ml−1
DMPC. Traces show the normalized Rayleigh ratio (red trace) and UV absorbance at 254 nm (blue trace) with overlaid mass calculations (black trace).
(e) SEC-MALS chromatograms obtained for SMI (green traces) and SMILPs made with 1.5% (w/v) SMI and 3, 5 and 7 mg mL−1 (black, red and blue
traces, respectively). UV absorbance traces at 254 nm are shown in the left hand graph any Rayleigh ratio traces with overlaid mass calculations
(colored circles) are shown in the right hand graph.
Table 2 Structural parameters obtained through ﬁtting of SAXS data
for DMPC-SMILP nanodiscs made with ﬁxed SMI concentration
(5.56 mM, 1.5% w/v) and varying DMPC concentrations, in 50 mM
sodium acetate, 200 mM NaCl, pH 5. All ratios are above the SOL
boundary. Parameters labelled with * were held constant though ﬁtting
using values previously determined for DMPC bilayers55. The full list of
ﬁt parameters is provided in the ESI (Table S1)
DMPC concentration/mg ml−1 3 5 7
Molar ratio [SMI] : [DMPC] 1.26 0.75 0.54
DMPC core diameter/nm 1.3 ± 0.2 1.9 ± 0.2 2.3 ± 0.2
SMI belt thickness/nm 1.7 ± 0.2 1.8 ± 0.2 1.6 ± 0.2
DMPC tail length/nm 2.76* 2.76* 2.76*
DMPC headgroup length/nm 0.8* 0.8* 0.8*
Overall diameter/nm 4.7 ± 0.6 5.5 ± 0.6 5.6 ± 0.6
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aggregation or precipitation and no peaks of larger diameter
were observed in the associated particle size distributions (see
ESI, Fig. S3†). These data indicate that SMILPs are a stable
platform which is ideal for applications involving the presence
of divalent cations and acidic pH.
SMILP solubilization of membrane proteins from biological
membranes
SMA has been widely utilized for the solubilization of mem-
brane proteins. We therefore investigated the eﬃciency of SMI
to solubilize membrane proteins directly from native
Escherichia coli (E. coli) membranes. The solubilizing capability
of SMI was compared to that of SMA2000 and to the detergent
n-dodecyl β-D-maltoside (DDM), which is commonly employed
for solubilizing functional membrane proteins. A control
where no solubilizing agent was added to the membranes was
also included (Fig. 5a). Soluble and insoluble fractions were
separated by ultracentrifugation and analyzed by SDS-PAGE.
SMILP-solubilized samples show a diﬀuse low molecular
weight band that results from the presence of polymer in the
soluble fractions at pH 5 and pH 7. Despite this, it is clear that
both SMI and DDM eﬀectively solubilize E. coli membrane pro-
teins, which are evident in the supernatant fraction (S) at both
pH values (Fig. 5a). In contrast, SMA is ineﬀective at pH 5. At
pH 7 however, both SMI and SMA eﬀectively solubilized mem-
brane proteins, consistent with the pH-dependence data of
SMILP and SMALP stability presented in Fig. 4a. However at
pH 7, SMI is less eﬀective than SMA or DDM.
Fig. 4 Stability of SMILPs. (a) The turbidity of SMALP and SMILP solutions as a function of pH. Data was recorded at concentrations of 0.33 mg mL−1
DMPC, 0.1% w/v SMA or SMI for SMALPs and SMILPs respectively, in 50 mM sodium phosphate, 200 mM NaCl. (b) The turbidity of SMALP and SMILP
solutions in response to increasing concentrations of Mg2+ or Ca2+. (c) DLS data showing the eﬀect of temperature on Z-average diameter
(magenta) and PDI (green) of DMPC-SMILPs (1.5% w/v SMI, 5 mg mL−1 DMPC, 50 mM sodium acetate, 200 mM NaCl, pH 5). Points represent the
mean value taken from three separate experiments with error bars displaying ±1 standard error. (d) DLS data showing the eﬀect of freeze–thaw
cycles on Z-average diameter (magenta) and PDI (green) of DMPC-SMILPs (1.5% w/v SMI, 5 mg mL−1 DMPC, 50 mM sodium acetate, 200 mM NaCl,
pH 5). Points represent the mean value taken from three separate experiments with error bars displaying ±1 standard error.
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In order to be widely adopted, SMILP-solubilized proteins
must be amenable to purification techniques. To investigate
the yield and purity of SMILP-solubilized compared to SMALP-
solubilized proteins, Ni2+-NTA immobilized metal aﬃnity
chromatography (IMAC) was performed on E. coli ZipA, which
has been previously used to determine the eﬃciency of
diﬀerent SMA polymers,38 after extraction with SMA and SMI
(Fig. 5b). The yield obtained when extracting ZipA using SMI is
marginally less than when using SMA, which is corroborated
by whole membrane extractions discussed above. Importantly,
SMILP-ZipA can be obtained at a higher purity than
SMALP-ZipA.
To investigate if the functional capability of membrane pro-
teins was preserved following encapsulation in a SMILP, two
G-protein-coupled receptors (GPCRs) were SMILP-solubilized.
The human adenosine A2A receptor (A2AR) and the human V1a
vasopressin receptor (V1aR) were each transiently expressed in
HEK 293T cells and the cells solubilized by SMI. The binding
capability of the SMI-solubilized membranes containing
GPCR-SMILPs was determined by radio-ligand binding assays
using [3H]ZM241385 as tracer ligand for the A2AR encapsulated
in a SMILP (A2AR-SMILP) and [
3H]vasopressin ([3H]AVP) as
tracer ligand for the V1aR-SMILP. Non-specific binding was
determined in each case by a saturating concentration (1 µM)
of unlabeled ligand. The SMILP-solubilized A2AR and V1aR
were both functional as specific binding to the receptor was
observed for both the A2AR-SMILP (Fig. 5c) and the
V1aR-SMILP (Fig. 5d), with 59 ± 6% and 42 ± 10% (mean ± s.e.
m.) of total binding being specific binding, respectively.
Summary and discussion
The similarity in the thermodynamic parameters for SMALP
self-assembly to those obtained for SMI show that there is a
similar thermodynamic driving force for the formation of both
SMALPs and SMILPs. In both cases it is the polymer that
drives this process, despite the electrostatic diﬀerences
between SMI and SMA. SMI shows a slightly larger negative
free energy change upon interaction with the lipids than SMA,
indicating a more favorable self-assembly. As with all other
polymers so far studied (SMA(2 : 1),33,34 SMA(3 : 1)21,37 and
DIBMA40) there is a small positive free energy change associ-
ated with DMPC moving from vesicle to nanodisc. This means
that SMI can be thought of as a mild membrane solubilizer,
since it eﬀectively keeps the lipid molecules in a free-energy
environment similar to that experienced in vesicles.
When comparing SMI to DIBMA, SMI is more eﬃcient at
initiating the onset of solubilization, although higher concen-
trations of SMI are required for completion of solubilization
than that of DIBMA. The free energy change associated with
DMPC during nanodisc formation is slightly less positive in
“DIBMALPs” than in SMILPs. The driving force for SMI to self-
assemble into nanodiscs is over twice as strong as DIBMA,
indicating SMILP formation is overall more thermo-
dynamically favored in comparison to DIBMALPs.
SMALPs have been widely reported to have diameters of
approximately 10 nm. Data presented here suggest that
SMILPs appear slightly smaller. By comparison, pH-resistant
SMA-QA polymers form ‘macro-nanodiscs’ with substantially
larger diameters up to approximately 30 nm (ref. 51) while the
acid-soluble SMAd-A has been observed to form nanodiscs
slightly smaller than observed for SMALPs: between
5–10 nm.50 Values from TEM, DLS and SEC-MALS suggest
SMILPs have diameters ranging from 12 to 6 nm, similar to
SMAd-A nanodiscs. A more in depth structural investigation of
SMILPs using SAXS suggest a smaller overall particle diameter
of around 5 nm. This discrepancy in SMILPs analyzed by TEM
appearing larger is likely due to negative staining by PTA
coating the particles, leading to a larger apparent diameter.
DLS and SEC-MALS are similarly aﬀected by the hydration
shell around SMILPs, with analysis assuming a spherical par-
Fig. 5 The solubilization of membrane proteins using SMI. (a)
Coomassie stained SDS-PAGE showing the range of proteins that have
been solubilized (S) and remained insoluble (I) after the incubation of
E. coli membranes with SMI compared to DDM SMA2000 at pH 5 and
pH 7. A control using membranes without the addition of SMI, DDM or
SMA is also shown. (b) Coomassie stained SDS-PAGE showing the rela-
tive yield and purity of E. coli His6-ZipA extracted with SMA compared
with SMI over six elutions (E1–E6) from Ni2+-NTA IMAC puriﬁcation. (c)
Binding of [3H]ZM241385 to A2AR-SMILP extracted from HEK 293T cells
expressing human A2AR. Non-speciﬁc binding was deﬁned by a saturat-
ing concentration (1 µM) of ZM241385. (d) Binding of [3H]vasopressin
([3H]AVP) to V1aR-SMILP extracted from HEK 293T cells expressing
human V1aR. Non-speciﬁc binding was deﬁned by a saturating concen-
tration (1 µM) of AVP. Binding data are mean ± s.e.m. of three separate
experiments performed in triplicate with total binding, non-speciﬁc
binding and speciﬁc binding shown in each case.
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ticle. SAXS is insensitive to these limitations, providing a more
accurate estimation of size, whilst also showing that the
adopted structure is consistent with the ‘nanodisc’ model pro-
posed for SMALPs. The presence of free SMI as determined by
SAXS and SEC-MALS may also explain the particle size distri-
bution seen by TEM. The population of smaller particles is
most likely due to aggregates formed by excess SMI. This is
similar to previous studies of oil microencapsulation by SMI.
However, it is also possible that the second population also
represents the second dimension of the SMILP nanodisc struc-
ture (i.e. it is slightly bigger than the “thickness” of the nano-
discs determined by SAXS: lipid tail + lipid head is ∼3.5 nm).
The parameters obtained from fitting SAXS data, taking
into account the presence of free SMI, indicate that SMILPs
are smaller than SMALPs due to a decreased diameter of the
phospholipid core. The diameter of the core, however,
increases slightly with an increased DMPC : SMI ratio while the
thickness of the SMI belt remains unchanged. These data are
in agreement with DLS data, suggesting that phospholipid par-
titions between the available polymer, leading to changes in
particle diameter for diﬀerent relative ratios of DMPC : SMI.
Interestingly, SEC-MALS data collected for SMILPs formed at
diﬀerent SMI : DMPC ratios indicate that once formed, excess
SMI aggregates can be removed and the diﬀerent sizes of
SMILPs can be maintained through purification. This could
have important application to membrane protein solubil-
ization whereby the size of the SMILP can be tuned to opti-
mally accommodate the target protein.
Two of the major limitations of SMALPs have been their
insolubility at acidic pH and their very low tolerance of di-
valent cations. SMILPs display the opposite pH dependence to
SMALPs, whilst being able to tolerate higher concentrations of
divalent cations than SMALPs and DIBMALPs. Meanwhile,
SMILPs show improved thermal stability relative to SMALPs,33
with demonstrated stability up to 80 °C and over many freeze–
thaw cycles. While a decrease in diameter is observed between
10 and 16 °C, the mechanism behind this change remains
unclear. While it could be indicative of minor lipid loss from
increased thermal motion of either the lipids or the polymer,
it is also possible that more subtle structural rearrangements
occur to which the DLS technique is insensitive. However,
regardless of the mechanism of this small change in SMILP
size, the absence of any large aggregates and relatively con-
stant PDI up to 80 °C indicate SMILPs provide a stable plat-
form for membrane protein solubilization.
When used to solubilize membrane proteins from biologi-
cal membranes, SMI is eﬀective below pH 7.8 and importantly
is eﬀective at the physiological relevant pH of 7.4. This is an
important attribute as it allows membrane proteins that
cannot tolerate low pH to be studied using SMILPs. The
decreased solubilization eﬃciency of SMI compared to SMA at
pH 7 may be due to the size of SMILPs. With such a small
lipid core, it is unclear how much native lipid can remain in
the SMILP in addition to a membrane protein. SMI does not
exhibit any selectivity towards the size of the proteins which
are solubilized within SMILPs, with both high and low Mw pro-
teins being equally represented. This is surprising given the
smaller diameter of the lipid core as determined by SAXS.
Although SMI forms nanodisc structures in the presence of
phospholipids alone, the addition of membrane proteins may
lead to SMI acting more as an amphipol rather than a nano-
disc, but with the benefit of being able to extract proteins
directly from cell membranes. Irrespective of the solubilization
mechanism, it is clear that the SMILP-solubilized GPCRs inves-
tigated here retain a conformation capable of ligand binding.
The A2AR and the V1aR have diﬀerent binding modes in that
the A2AR binds small biogenic amine ligands within the trans-
membrane helical bundle whereas the V1aR binds larger nona-
peptides to a binding site comprising extracellular elements in
addition to the helical bundle.57 Despite diﬀerences in their
binding modes, both A2AR-SMILP and V1aR-SMILP retained
ligand binding capability. In each case non-specific binding of
radio-ligand was expected, resulting from low level ligand par-
titioning into the lipid bilayer, or the SMI polymer belt.
However, the degree of non-specific binding when using
GPCR-SMILPs is similar to previously observed for
GPCR-SMALPs and low enough to allow accurate measurement
of specific binding. The non-specific binding of [3H]ZM241385
to A2AR-SMILP was 41 ± 5.3% of total binding, compared to 39
± 3.8% observed for [3H]ZM241385 binding to the same recep-
tor in a SMALP (A2AR-SMALP).
23 Consequently, using GPCRs
as an example, it has been shown that SMI-solubilized mem-
brane proteins remain functional. Furthermore, SMILP-solu-
bilized ZipA can be obtained to a higher degree of purity than
SMALP-solubilized ZipA, albeit at a slightly lower yield. This
could have important implications for applications such as
electron microscopy, where only micrograms of sample are
required but at a very high level of purity.
Conclusions
Nanodisc technology is becoming widely adopted as a mem-
brane and membrane protein solubilization strategy. The
recent development of SMALP nanodiscs provides benefits
over other alternative solubilization strategies by being able to
solubilize membrane proteins directly from the host cell mem-
brane whilst keeping the annular lipids present within the
nanodisc to maintain the native environment of the mem-
brane protein.29 SMALPs however are limited by two predomi-
nant factors: insolubility at low pH and precipitation in the
presence of divalent cations.
We have presented data showing that the positively charged
SMI polymer can self-assemble in the presence of phospho-
lipids in acidic conditions to form SMI lipid particle (SMILP)
nanodiscs which are both thermally stable and stable in the
presence of divalent cations. SMI is also capable of extracting
functional membrane proteins directly from biological
membranes.
Recent developments in nanodisc-forming polymers have
resulted in a range of polymers capable of forming nanodiscs
which can solubilize membrane proteins. These polymers,
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now with the addition of SMI, provide a nanodisc toolbox for
the study of membrane proteins, where the nanodisc can be
tuned to application. For example, SMA has been successfully
utilised for structural studies of membrane proteins by elec-
tron microscopy,24,32 X-ray crystallography,31 and solid-state
NMR30 as well as functional studies.23,25,29 However, the limit-
ations discussed above still apply. For solubilization of larger
membrane proteins or complexes, a larger nanodisc may be
required. High resolution cryo-transmission electron
microscopy also benefits from a larger particle. It has been
demonstrated that SMA polymers synthesised by random
addition fragmentation chain transfer (RAFT) polymerisation
can form larger nanodiscs43 which would be suited for these
studies. Similarly, macro-nanodiscs formed by SMA-QA51 and
SMA-EA48,49 may prove advantageous for study of membrane
proteins by electron microscopy. In addition, structural studies
of membrane proteins by 2D solid-state NMR could benefit
from the demonstrated magnetic alignment properties of
SMA-QA and SMA-EA nanodiscs. For downstream spectro-
scopic applications such as circular dichroism, DIBMA40 and
PMA47 are ideal polymers due to the absence of the styrene
moiety leading to non-overlapping UV-absorbance signals
from the polymer and solubilized proteins. Sulfhydryl-modi-
fied SMA (SMA-SH)44 is capable of solubilizing membrane pro-
teins and is ideal for fluorescence studies and surface-coupling
applications such as surface plasmon resonance, where
specific chemistries can be easily added to the polymer. Now,
we have shown that SMI is the ideal polymer for the solubil-
ization of membrane proteins that require acidic pH or the
presence of high concentrations of divalent cations directly
from biological membranes. For example, membrane-associ-
ated ATPase enzymes41 and the calcium dependant potassium
channel superfamily42 require Mg2+ or Ca2+ for activity, which
would be incompatible with the SMALP system.
Having demonstrated the potential of SMILPs, we will con-
tinue our studies of this system to obtain more detail on the
structure, function and the mechanism by which it operates.
As a first step we have already performed neutron small angle
scattering measurements (data currently under analysis) that
will provide improved structural detail on the size and shape
of SMILPs.
Taken together these data show that SMILPs address some
of the long-standing limitations of SMALPs and other existing
nanodisc forming polymers. Together this makes SMILPs and
important addition to the membrane nanodisc toolbox.
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